Skip to content

Pulse Oximeter Motion Study

Four Types of Pulse Oximeters Accurately Detect Hypoxia During Low Perfusion and Motion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03156140
Acronym
Motion
Enrollment
10
Registered
2017-05-17
Start date
2016-06-01
Completion date
2016-08-31
Last updated
2017-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia

Brief summary

Evaluate the performance of 4 pulse oximeters in 10 healthy adult volunteers with three motions compared to non-motion control at three arterial oxygen saturation target plateaus.

Detailed description

Evaluate the performance of 4 pulse oximeters (Masimo Radical-7, Nihon-Koden OxyPal Neo, Nellcor N-600, and Philips Intellivue MP5) in 10 healthy adult volunteers. Three motions will be evaluated: tapping, pseudorandom, and volunteer-generated rubbing, adjusted to produce photoplethsmogram disturbance similar to arterial pulsation amplitude. During motion, inspired gases will be adjusted to achieve stable target plateaus of arterial oxygen saturation (SaO2) at 75%, 88%, and 100%. Pulse oximeter readings (SpO2) will be compared with SaO2 from simultaneous arterial blood samples

Interventions

OTHERMotion

Volunteer has motion on right hand while with continuous pulse oximetry during three oxygenation plateaus

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

healthy adult English speaking -

Exclusion criteria

pediatric, cardiac or pulmonary condition. non-english speaking \-

Design outcomes

Primary

MeasureTime frame
Pulse oximetry readingimmediate

Secondary

MeasureTime frame
Arterial Blood gasimmediate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026